Indian Phosphate starts new Labsa plant in Cuddalore
Indian Phosphate Limited commenced operations at its new Labsa manufacturing plant in Cuddalore, Tamil Nadu, on June 29, 2026. Funded by IPO proceeds, the facility aims to boost production capacity and support the company's expansion strategy.

*this image is generated using AI for illustrative purposes only.
Indian Phosphate Limited has commenced operations at its newly established Labsa manufacturing plant in Cuddalore, Tamil Nadu, significantly enhancing its production capacity and geographical presence. The new facility, funded through IPO proceeds, supports the company's expansion strategy and addresses the growing demand for its products.
The project was financed using capital raised during the company's initial public offering, as previously disclosed in the offer document. This strategic investment is expected to bolster the company's manufacturing capabilities and market reach.
Key Details of the New Facility
| Aspect | Details |
|---|---|
| Location | Cuddalore, Tamil Nadu |
| Product | Labsa |
| Funding Source | IPO Proceeds |
| Strategic Objective | Expansion and capacity enhancement |
The commencement of operations at this plant marks a significant milestone in Indian Phosphate 's growth trajectory. The company had previously informed the exchanges about the utilization of IPO funds for this expansion project.
Ravindra Singh, Managing Director of Indian Phosphate Limited, confirmed the development in a regulatory filing submitted on June 29, 2026. The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Indian Phosphate
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.39% | -3.39% | -5.09% | -10.28% | -2.26% | -69.73% |
What is the projected revenue contribution from the new Cuddalore facility in the upcoming fiscal year?
How will the increased production capacity impact Indian Phosphate's competitive position in the Labsa market?
Are there plans for further expansion or diversification into other chemical products using remaining IPO proceeds?





























